FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Mexican Consulates Worry That Trump Admin Review Could Lead To Closure

California 22nd Congressional district primary results: Rep. David Valadao advances to runoff

Hilton, Becerra, in the lead with votes still being counted in battle for California governor

California 11th district primary results: Wiener advances to general election to succeed Pelosi

South Dakota governors race remains up in the air as GOP contest goes to runoff

Supreme Court allows Alabama GOP-backed congressional map for midterms

Trump-endorsed Feenstra concedes to MAHA-backed Lahn in GOP governor primary upset

DOJ expands indictment against SPLC, alleging $4M secretly funneled to KKK and extremist groups

FBI charges 35 in West Virginia drug and firearms operation, launches nationwide summer crime initiative

Missing GOP congressman reveals he’s ‘more energized than ever’ to return to Washington

Bomb threat standoff at Bakersfield Chase Bank continues as negotiators work to release hostages

WATCH: Dem senators excuse Platner’s conduct at crisis huddle with embattled Maine candidate

Trump-backed candidate ‘confident’ Republicans will have great night in California: ‘Very excited’

Jill Biden Claims Joe Would Have Beaten Trump If Democrats Hadn’t Forced Him Out

Trump Signs Modified AI Executive Order Behind Closed Doors

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”